Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tailored Tobacco Intervention

NCT01892813 is registered in ClinicalTrials.gov with Mark Vander Weg as lead sponsor.

NCT NCT01892813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01892813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tailored Tobacco Intervention
Lead sponsor
Mark Vander Weg
Phase
Phase 3
Overall status
Unknown status
Start date
July 31, 2013
Completion date
January 31, 2018
Enrollment
411 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nicotine dependence, tobacco use